Literature DB >> 7395585

The menarche experience in twenty-three foreign countries.

D D Logan.   

Abstract

Ninety-five women (aged 18-26) from 23 countries were interviewed regarding their first menstrual experience. Among the areas discussed were (1) their preparation for menarche, (2) messages from others at the time of menarche, and (3) their own emotional reactions to the first period. Although the mother, as might be expected, was the main source of information, almost one-third of the girls received no maternal assistance prior to menarche. The chief reaction of others to a girl's first period centered on help with the hygienic routine. Only in Iran was a non-hygienic response more common--reassurance of the normality of the event. The emotional reactions of the women themselves differed widely. Asians most often reported feeling "embarrassed" and "surprised." In contrast, Iranians most frequently mentioned feeling "more grown up". The discussion includes a comparison of the international women's descriptions of their menarche with data available on American samples. Finally, the paper concludes with an analysis of the importance of a culture's response to the menarcheal female.

Entities:  

Mesh:

Year:  1980        PMID: 7395585

Source DB:  PubMed          Journal:  Adolescence        ISSN: 0001-8449


  3 in total

Review 1.  Black adolescents' emotional response to menarche.

Authors:  C S Scott; D Arthur; R Owen; M I Panizo
Journal:  J Natl Med Assoc       Date:  1989-03       Impact factor: 1.798

2.  Timing of menarche, preparation, and initial menstrual experience: Replication and further analyses in a prospective study.

Authors:  J Rierdan; E Koff; M L Stubbs
Journal:  J Youth Adolesc       Date:  1988-10

3.  Experiences of menstruation in high income countries: A systematic review, qualitative evidence synthesis and comparison to low- and middle-income countries.

Authors:  Dani Jennifer Barrington; Hannah Jayne Robinson; Emily Wilson; Julie Hennegan
Journal:  PLoS One       Date:  2021-07-21       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.